SBS-IF is the second orphan disease target indication for Jaguar’s intestinal failure program, which includes microvillus inclusion disease (MVID) – for which the company completed a meeting in ...

It seems that every day brings a new artificial intelligence solution to health care, with providers able to automate myriad ...

The Accepted Abstract Provides Supportive Evidence for the TAMP™ Therapy Platform’s Novel, Localized Approach to Targeted Chemotherapeutic Delivery via Additional Pharmacokinetic and Pharmacodynamic D ...

The next wave of cloud evolution will center on converged data security platforms—architectures that unify policy enforcement ...

U.S. residential electricity prices are expected to keep climbing in 2026, averaging about 18.02¢/kWh, up from 17.29¢/kWh in ...

Mid-Atlantic Permanente Medical Group shows how trusted data and technology can turn value-based care into better outcomes, ...

EFLM recognizes Babson Diagnostics for innovations in sample collection and preparation ...

("Profusa” or the "Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation ...

An analysis for the Ministry of the Interior highlights the reach of US laws. According to it, data stored in the EU is also ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Detailed price information for Briacell Therapeutics Corp (BCT-T) from The Globe and Mail including charting and trades.

Senators Shelley Moore Capito and Amy Klobuchar have moved to confront one of the fastest growing consumer threats of the ...